Riskpilot← Back to searchSign inGet full accessANICURA EIDSVOLL DYREKLINIKK AS
ASActiveOrg 913476743Botshaugtangen 42A, 2080 EidsvollVeterinary activities · NACE 7500Est. 201417 employees
Revenue 2022
NOK 18,3M
-6% vs 2021
EBITDA margin
25.1%
-20% vs 2021
Equity ratio
12.4%
Financial strength
Net profit 2022
NOK 3,3M
-21% vs 2021
| Revenue | NOK 18,3M | -6% |
| EBITDA | NOK 4,6M | -20% |
| Net profit | NOK 3,3M | -21% |
| Total assets | NOK 8,4M | -2% |
| Equity | NOK 1M | +27% |
| Employees | 17 | — |
Legal name
ANICURA EIDSVOLL DYREKLINIKK AS
Org number
913476743
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
7. april 2014
Share capital
NOK 3 000 000
Employees
17 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Å drive veterinærtjenester, samt utleie av utstyr og eiendom/lokaler, samt oppgaver i tilknytning til dette, herunder deltagelse i andre selskaper med samme eller lignende formål
Address
Botshaugtangen 42A, 2080 Eidsvoll
Phone
+4763962220
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 14 953 | 16 001 | 18 391 | 19 513 | 18 264 |
| Staff expenses | −4 401 | −4 923 | −5 374 | −6 640 | −6 627 |
| EBITDA | 4 092 | 4 661 | 6 638 | 5 755 | 4 578 |
| Depreciation & amort. | −332 | −447 | −585 | −456 | −474 |
| EBIT | 3 761 | 4 214 | 6 053 | 5 299 | 4 104 |
| Net financials | 82 | 68 | 68 | 82 | 150 |
| Profit before tax | 3 842 | 4 282 | 6 121 | 5 381 | 4 254 |
| Tax | 885 | 939 | 1 347 | 1 184 | 936 |
| Net profit | 2 957 | 3 342 | 4 774 | 4 198 | 3 318 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 6 554 | 7 407 | 9 456 | 8 518 | 8 373 |
| Equity | 430 | 473 | 551 | 823 | 1 041 |
| Long-term debt | 0 | 0 | 0 | 76 | 138 |
| Short-term debt | 6 124 | 6 934 | 8 905 | 7 619 | 7 194 |
| Total debt | 6 124 | 6 934 | 8 905 | 7 695 | 7 332 |
EBITDA margin
25.1%
This company
15.8%
Market median
+59% vs market
20182022
Equity ratio
12.4%
This company
38.2%
Market median
-68% vs market
20182022
Return on equity
318.8%
This company
18.4%
Market median
+1633% vs market
20182022
Net profit margin
18.2%
This company
8.1%
Market median
+125% vs market
20182022
Asset turnover
2.18×
This company
1.12×
Market median
+95% vs market
20182022
Debt / equity
7.04×
This company
0.62×
Market median
-1035% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RT Chief Executive Officer | Chief Executive Officer | 2015 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Former (1) | ||
| Chairman | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Anicura As
ANICURA EIDSVOLL DYREKLINIKK AS Board members of ANICURA EIDSVOLL DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rolf Terje Nyen | Chief Executive Officer | 0 companies |
| Jørn Dreyer | Chairman | 0 companies |
| Lill Nyseter Kortgaard | Chairman | 0 companies |